J. Graham Sharp

Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies.

Michael Bishop, Patrick L. Iversen, Eliel Bayever et al. · Journal of Clinical Oncology · 1996 · 141 citations

Medicine, Oncology, Pharmacology +14

Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest.

J. Graham Sharp, Anne Kessinger, SL Mann et al. · Journal of Clinical Oncology · 1996 · 136 citations

Medicine, Hematology, Oncology +16

Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique

J. Graham Sharp, SS Joshi, JO Armitage et al. · Blood · 1992 · 118 citations · Full text

Medicine, Oncology, Pathology +14

Detection and clinical significance of minimal tumor cell contamination of peripheral stem call harvests

J. Graham Sharp, Anne Kessinger, William P. Vaughan et al. · Stem Cells · 1992 · 107 citations

Medicine, Oncology, Pathology +16

Comparison of Molecular Cytokeratin 19 Reverse Transcriptase Polymerase Chain Reaction (CK19 RT-PCR) and Immunocytochemical Detection of Micrometastatic Breast Cancer Cells in Hematopoietic Harvests

Monica D. Traystman, S J Hake, Charles Kuszynski et al. · Journal of Hematotherapy · 1997 · 31 citations

Medicine, Oncology, Pathology +17